Susquehanna International Group, LLP Ovid Therapeutics Inc. Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.98 - $3.78 $66,215 - $83,991	22,220 New	22,220 $71,000
Q2 2023 Aug 11, 2023	SELL	$2.53 - $3.89 $371,424 - $571,083	-146,808 Reduced 89.64%	16,958 $55,000
Q1 2023 May 16, 2023	BUY	$1.88 - $2.85 $285,227 - $432,393	151,717 Added 1259.17%	163,766 $422,000
Q4 2022 Feb 14, 2023	BUY	$1.43 - $1.86 $17,230 - $22,411	12,049 New	12,049 $22,000
Q1 2022 May 16, 2022	BUY	$2.65 - $3.49 $56,985 - $75,048	21,504 Added 7.51%	307,874 $967,000

Q4 2021 Feb 14, 2022	BUY	$3.13 - $3.73 $278,898 - $332,361	89,105 Added 45.17%	286,370 $919,000
Q3 2021 Nov 15, 2021	BUY	$3.31 - $4.04 $299,703 - $365,801	90,545 Added 84.84%	197,265 $663,000
Q2 2021 Aug 11, 2021	SELL	$3.3 - $4.49 $263,613 - $358,674	-79,883 Reduced 42.81%	106,720 $417,000
Q1 2021 May 17, 2021	BUY	$2.42 - $4.47 $56,734 - $104,794	23,444 Added 14.37%	186,603 $750,000
Q4 2020 Feb 16, 2021	BUY	$2.28 - $6.84 $303,876 - $911,628	133,279 Added 446.05%	163,159 $377,000
Q3 2020 Nov 16, 2020	SELL	$5.39 - $8.24 $217,772 - $332,920	-40,403 Reduced 57.49%	29,880 $172,000
Q2 2020 Aug 14, 2020	SELL	$2.67 - $7.91 $628,568 - $1.86 Million	-235,419 Reduced 77.01%	70,283 $518,000
Q1 2020 May 15, 2020	BUY	$2.03 - $4.35 $384,415 - $823,746	189,367 Added 162.78%	305,702 $911,000
Q4 2019 Feb 14, 2020	BUY	$2.08 - $5.06 $241,976 - $588,655	116,335 New	116,335 $483,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.